Hysteroscopic Morcellation of Submucous Myomas: A Systematic Review. (29th August 2017)

• Record Type: Journal Article
• Authors: Vitale, Salvatore Giovanni; Sapia, Fabrizio; Rapisarda, Agnese Maria Chiara; Valenti, Gaetano; Santangelo, Fabrizia; Rossetti, Diego; Chiofalo, Benito; Sarpietro, Giuseppe; La Rosa, Valentina Lucia; Triolo, Onofrio; Noventa, Marco; Gizzo, Salvatore; Laganà, Antonio Simone
• Other Names: Wallwiener Markus Academic Editor.
• Is Part Of: BioMed research international. Volume 2017(2017)
• Publication Date: 2017-08-29
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Life sciences -- Periodicals; 610.5
• DOI: 10.1155/2017/6848250
• Languages: English
• ISSNs: 2314-6133

Abstract

Abstract : Hysteroscopic surgery is the actual gold standard treatment for several types of intrauterine pathologies, including submucous myomas (SMs). To date, the availability of Hysteroscopic Tissue Removal systems (HTRs) opened a new scenario. Based on these elements, the aim of this article is to review the available evidence about HTRs for the management of SMs. We included 8 papers (3 prospective studies and 5 retrospective studies). A total of 283 women underwent intrauterine morcellation of SM: 208 were treated using MyoSure and 75 using Truclear 8.0. Only 3 articles reported data about procedures performed in outpatient/office setting. Only half of the included studies included type 2 SMs. HTRs significantly reduced operative time compared to traditional resectoscopy in some studies, whereas others did not find significant differences. Despite the availability of few randomized controlled trials and the cost of the instrument, according to our systematic review, the use of HTRs seems to be a feasible surgical option in terms of operative time and complications. Nevertheless, the type of SM still remains the biggest challenge: type 0 and 1 SMs are easier to manage with respect to type 2, reflecting what already is known for the "classic" hysteroscopic myomectomy.